Farallon Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,225,000
| Closed | -$167M | – | 161 |
|
|
2020
Q3 | $167M | Buy |
1,225,000
+350,000
| +40% | +$37.2M | 1.16% | 34 |
|
|
2020
Q2 | $84.5M | Buy |
875,000
+445,000
| +103% | +$37.1M | 0.68% | 42 |
|
|
2020
Q1 | $20.2M | Sell |
430,000
-1,620,000
| -79% | -$104M | 0.17% | 68 |
|
|
2019
Q4 | $149M | Buy |
2,050,000
+19,603
| +1% | +$1.19M | 1.01% | 32 |
|
|
2019
Q3 | $106M | Buy |
2,030,397
+30,397
| +2% | +$1.62M | 0.8% | 32 |
|
|
2019
Q2 | $100M | Buy |
2,000,000
+49,722
| +3% | +$2.42M | 0.65% | 34 |
|
|
2019
Q1 | $101M | Buy |
1,950,278
+350,000
| +22% | +$16.1M | 0.76% | 36 |
|
|
2018
Q4 | $78.2M | Buy |
1,600,278
+69,000
| +5% | +$3.8M | 0.57% | 38 |
|
|
2018
Q3 | $99.8M | Buy |
1,531,278
+50,000
| +3% | +$2.94M | 0.59% | 35 |
|
|
2018
Q2 | $73.5M | Buy |
1,481,278
+442,000
| +43% | +$21.4M | 0.45% | 42 |
|
|
2018
Q1 | $50.7M | Buy |
1,039,278
+175,546
| +20% | +$9.13M | 0.35% | 50 |
|
|
2017
Q4 | $36.4M | Buy |
863,732
+466,232
| +117% | +$18M | 0.3% | 45 |
|
|
2017
Q3 | $17M | Buy |
+397,500
| New | +$12.7M | 0.15% | 60 |
|